BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33552967)

  • 1. Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management.
    Zhou X; Liu P; Wang X
    Front Oncol; 2020; 10():593487. PubMed ID: 33552967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Changes in Cognitive Function in Patients With Radiation-Induced Temporal Lobe Necrosis After IMRT for Nasopharyngeal Cancer.
    Liu P; Niu X; Ou D; Qiu J; Lou P; Xue L; Zhou X; Xu T; Wang X
    Front Oncol; 2020; 10():450. PubMed ID: 32391255
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management.
    Chen J; Dassarath M; Yin Z; Liu H; Yang K; Wu G
    Radiat Oncol; 2011 Sep; 6():128. PubMed ID: 21961805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
    Wu L; Chung YL
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
    Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma.
    Wong ST; Loo KT; Yam KY; Hung WM; Fok KF; Yuen SC; Fong D
    J Neurosurg; 2010 Aug; 113(2):293-300. PubMed ID: 20151776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
    Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
    Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.
    Lin J; Lv X; Niu M; Liu L; Chen J; Xie F; Zhong M; Qiu S; Li L; Huang R
    Neuroimage Clin; 2017; 14():610-621. PubMed ID: 28348952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Zhang B; Mo Z; Du W; Wang Y; Liu L; Wei Y
    Oral Oncol; 2015 Nov; 51(11):1041-1046. PubMed ID: 26296274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
    Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
    Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy.
    Wang J; Miao Y; Ou X; Wang X; He X; Shen C; Ying H; Hu W; Hu C
    Radiat Oncol; 2019 Mar; 14(1):42. PubMed ID: 30866964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Du T; Xiao J; Qiu Z; Wu K
    PLoS One; 2019; 14(7):e0219611. PubMed ID: 31291379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
    Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
    Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
    Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
    Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
    Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cerebral radiation necrosis with nerve growth factor: A prospective, randomized, controlled phase II study.
    Wang XS; Ying HM; He XY; Zhou ZR; Wu YR; Hu CS
    Radiother Oncol; 2016 Jul; 120(1):69-75. PubMed ID: 27181260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
    Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.